Opinion: HIV care is threatened by proposed changes to Medicare Part D
Successfully treating HIV, and the even greater goal of ending the HIV pandemic, are based on a fundamental science-backed premise: that all people living with HIV should have early and uninterrupted access to effective antiretroviral medications that suppress the virus and keep it at undetectable levels for the rest of their lives. That premise for optimal HIV care, along with the great progress that has been made against HIV, is now threatened by proposed changes to Medicare aimed at lowering drug prices. That’s a terrible trade-off.
Effective treatment of HIV that begins as early as possible after infection and continues without interruption has well-established benefits. That is a powerful tool for ending the HIV epidemic.
You’re reading a preview, subscribe to read more.
Start your free 30 days